A new poll reveals a concerning trend: nearly two-thirds of men aged 55-69 have not been screened for prostate cancer, leading to a rise in advanced-stage diagnoses. Experts are urging men to ...

OU Health Stephenson Cancer Center is raising awareness of prostate cancer.

(UroToday.com) The 2025 ASTRO annual meeting featured a biomarker breakthroughs prostate cancer session and a discussant presentation by Dr. Alan Dal Pra. Dr. Dal Pra noted that amongst the six ...

Several medical conditions can mimic prostate cancer, causing many of the same symptoms, including painful ejaculation and ...

Newer evidence from the POP-RT phase III trial did show that pelvic nodal radiation for high-risk, locally advanced prostate ...

The FDA agrees that the Company may follow 505(b)(2) regulatory pathway to non-invasively treat basal cell carcinoma (BCC) of the skin using dissolvable Doxorubicin-containing Microneedle arrays ...

In September 2025, the U.S. Food and Drug Administration (FDA) approved several new cancer therapies and supportive care ...

Dr. Yeon Soo Kim, a postdoctoral fellow in Dr. Andrew Hsieh’s lab at Fred Hutch, has won a NIH Pathway to Independence Award ...

The blood test is capable of detecting 50 cancer types and subtypes, including the ones considered most deadly, like pancreatic, ovarian, liver, esophageal, lung, and stomach cancers. Currently, it’s ...

At ASTRO, Artera presented clinical validation data on its prostate cancer test in an Asian population,and showed how the test may complement gene expression-based approaches.

Females between 40 and 44 may start getting a mammorgram every year. Females 55 and older may get a mammogram every other ...

A shorter radiation course improved quality of life among men with intermediate-risk, localized prostate cancer, according to ...